These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 26195137)

  • 1. Methyl-substitution of an iminohydantoin spiropiperidine β-secretase (BACE-1) inhibitor has a profound effect on its potency.
    Egbertson M; McGaughey GB; Pitzenberger SM; Stauffer SR; Coburn CA; Stachel SJ; Yang W; Barrow JC; Neilson LA; McWherter M; Perlow D; Fahr B; Munshi S; Allison TJ; Holloway K; Selnick HG; Yang Z; Swestock J; Simon AJ; Sankaranarayanan S; Colussi D; Tugusheva K; Lai MT; Pietrak B; Haugabook S; Jin L; Chen IW; Holahan M; Stranieri-Michener M; Cook JJ; Vacca J; Graham SL
    Bioorg Med Chem Lett; 2015 Nov; 25(21):4812-4819. PubMed ID: 26195137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyridinyl aminohydantoins as small molecule BACE1 inhibitors.
    Zhou P; Li Y; Fan Y; Wang Z; Chopra R; Olland A; Hu Y; Magolda RL; Pangalos M; Reinhart PH; Turner MJ; Bard J; Malamas MS; Robichaud AJ
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2326-9. PubMed ID: 20202842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2D QSAR studies on series of human beta-secretase (BACE-1) inhibitors.
    Cruz DS; Castilho MS
    Med Chem; 2014 Mar; 10(2):162-73. PubMed ID: 23627297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New pyrazolyl and thienyl aminohydantoins as potent BACE1 inhibitors: exploring the S2' region.
    Malamas MS; Erdei J; Gunawan I; Barnes K; Hui Y; Johnson M; Robichaud A; Zhou P; Yan Y; Solvibile W; Turner J; Fan KY; Chopra R; Bard J; Pangalos MN
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5164-70. PubMed ID: 21835615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure based design of iminohydantoin BACE1 inhibitors: identification of an orally available, centrally active BACE1 inhibitor.
    Cumming JN; Smith EM; Wang L; Misiaszek J; Durkin J; Pan J; Iserloh U; Wu Y; Zhu Z; Strickland C; Voigt J; Chen X; Kennedy ME; Kuvelkar R; Hyde LA; Cox K; Favreau L; Czarniecki MF; Greenlee WJ; McKittrick BA; Parker EM; Stamford AW
    Bioorg Med Chem Lett; 2012 Apr; 22(7):2444-9. PubMed ID: 22390835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-organizing molecular field analysis on human β-secretase nonpeptide inhibitors: 5, 5-disubstituted aminohydantoins.
    Li Z; Zhou M; Wu F; Li R; Ding Z
    Eur J Med Chem; 2011 Jan; 46(1):58-64. PubMed ID: 21093114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3,3-Difluoro-3,4,5,6-tetrahydropyridin-2-amines: Potent and permeable BACE-1 inhibitors.
    Peschiulli A; Oehlrich D; Rombouts F; Vos A; Gijsen HJ
    Bioorg Med Chem Lett; 2020 Apr; 30(8):126999. PubMed ID: 32089426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of spiropiperidine hydantoins as a novel class of antimalarial agents.
    Meyers MJ; Anderson EJ; McNitt SA; Krenning TM; Singh M; Xu J; Zeng W; Qin L; Xu W; Zhao S; Qin L; Eickhoff CS; Oliva J; Campbell MA; Arnett SD; Prinsen MJ; Griggs DW; Ruminski PG; Goldberg DE; Ding K; Liu X; Tu Z; Tortorella MD; Sverdrup FM; Chen X
    Bioorg Med Chem; 2015 Aug; 23(16):5144-50. PubMed ID: 25797165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Di-substituted pyridinyl aminohydantoins as potent and highly selective human beta-secretase (BACE1) inhibitors.
    Malamas MS; Barnes K; Johnson M; Hui Y; Zhou P; Turner J; Hu Y; Wagner E; Fan K; Chopra R; Olland A; Bard J; Pangalos M; Reinhart P; Robichaud AJ
    Bioorg Med Chem; 2010 Jan; 18(2):630-9. PubMed ID: 20045648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and X-ray crystallographic analysis of a spiropiperidine iminohydantoin inhibitor of beta-secretase.
    Barrow JC; Stauffer SR; Rittle KE; Ngo PL; Yang Z; Selnick HG; Graham SL; Munshi S; McGaughey GB; Holloway MK; Simon AJ; Price EA; Sankaranarayanan S; Colussi D; Tugusheva K; Lai MT; Espeseth AS; Xu M; Huang Q; Wolfe A; Pietrak B; Zuck P; Levorse DA; Hazuda D; Vacca JP
    J Med Chem; 2008 Oct; 51(20):6259-62. PubMed ID: 18811140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of fragment-based NMR screening, X-ray crystallography, structure-based design, and focused chemical library design to identify novel microM leads for the development of nM BACE-1 (beta-site APP cleaving enzyme 1) inhibitors.
    Wang YS; Strickland C; Voigt JH; Kennedy ME; Beyer BM; Senior MM; Smith EM; Nechuta TL; Madison VS; Czarniecki M; McKittrick BA; Stamford AW; Parker EM; Hunter JC; Greenlee WJ; Wyss DF
    J Med Chem; 2010 Feb; 53(3):942-50. PubMed ID: 20043700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 4-Oxo-1,4-dihydro-quinoline-3-carboxamides as BACE-1 inhibitors: synthesis, biological evaluation and docking studies.
    Liu P; Niu Y; Wang C; Sun Q; Zhai Y; Yu J; Sun J; Xu F; Yan G; Huang W; Liang L; Xu P
    Eur J Med Chem; 2014 May; 79():413-21. PubMed ID: 24763262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of 5,5'-disubstituted aminohydantoins as potent and selective human beta-secretase (BACE1) inhibitors.
    Malamas MS; Erdei J; Gunawan I; Turner J; Hu Y; Wagner E; Fan K; Chopra R; Olland A; Bard J; Jacobsen S; Magolda RL; Pangalos M; Robichaud AJ
    J Med Chem; 2010 Feb; 53(3):1146-58. PubMed ID: 19968289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of fragment screening by X-ray crystallography to the discovery of aminopyridines as inhibitors of beta-secretase.
    Congreve M; Aharony D; Albert J; Callaghan O; Campbell J; Carr RA; Chessari G; Cowan S; Edwards PD; Frederickson M; McMenamin R; Murray CW; Patel S; Wallis N
    J Med Chem; 2007 Mar; 50(6):1124-32. PubMed ID: 17315857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diastereoselective synthesis of fused cyclopropyl-3-amino-2,4-oxazine β-amyloid cleaving enzyme (BACE) inhibitors and their biological evaluation.
    Low JD; Bartberger MD; Cheng Y; Whittington D; Xue Q; Wood S; Allen JR; Minatti AE
    Bioorg Med Chem Lett; 2018 Apr; 28(6):1111-1115. PubMed ID: 29426770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent pyrrolidine- and piperidine-based BACE-1 inhibitors.
    Iserloh U; Wu Y; Cumming JN; Pan J; Wang LY; Stamford AW; Kennedy ME; Kuvelkar R; Chen X; Parker EM; Strickland C; Voigt J
    Bioorg Med Chem Lett; 2008 Jan; 18(1):414-7. PubMed ID: 18023580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based design of novel dihydroisoquinoline BACE-1 inhibitors that do not engage the catalytic aspartates.
    Bowers S; Xu YZ; Yuan S; Probst GD; Hom RK; Chan W; Konradi AW; Sham HL; Zhu YL; Beroza P; Pan H; Brecht E; Yao N; Lougheed J; Tam D; Ren Z; Ruslim L; Bova MP; Artis DR
    Bioorg Med Chem Lett; 2013 Apr; 23(7):2181-6. PubMed ID: 23465612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and optimization of a novel spiropyrrolidine inhibitor of β-secretase (BACE1) through fragment-based drug design.
    Efremov IV; Vajdos FF; Borzilleri KA; Capetta S; Chen H; Dorff PH; Dutra JK; Goldstein SW; Mansour M; McColl A; Noell S; Oborski CE; O'Connell TN; O'Sullivan TJ; Pandit J; Wang H; Wei B; Withka JM
    J Med Chem; 2012 Nov; 55(21):9069-88. PubMed ID: 22468999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyramine fragment binding to BACE-1.
    Kuglstatter A; Stahl M; Peters JU; Huber W; Stihle M; Schlatter D; Benz J; Ruf A; Roth D; Enderle T; Hennig M
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1304-7. PubMed ID: 18226904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's disease: identification and development of β-secretase (BACE-1) binding fragments and inhibitors by dynamic ligation screening (DLS).
    Fernández-Bachiller MI; Horatscheck A; Lisurek M; Rademann J
    ChemMedChem; 2013 Jul; 8(7):1041-56. PubMed ID: 23757181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.